INCY FDA calendar & decision history INCYTE CORP · 1 upcoming · 7 past FDA decisions
Upcoming FDA catalysts INCY · Sep 26, 2026 zilurgisertib FDA decision history (7) May 1, 2026✓ Approved Jakafi XR (ruxolitinib) Apr 8, 2026✕ CRL ZYNYZ (retifanlimab-dlwr) - (P Sep 19, 2025✓ Approved FDA decision Jun 18, 2025✓ Approved FDA decision Jun 15, 2025✕ CRL FDA decision May 15, 2025✓ Approved FDA decision Jan 16, 2025✓ Approved FDA decision See the full 2026 PDUFA calendar → This page aggregates INCY's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent service; "FDA", "PDUFA", and all company, drug, and ticker names are used descriptively and remain the property of their owners. Informational and educational only — not investment advice. Data and historical statistics only; no trade recommendations and no individual-drug approval probabilities. Verify every date and outcome against primary FDA / SEC / company filings. © 2026 pdufa.bio